LH
LABCORP HOLDINGS INC.
Services-Medical Laboratories- 売上
- $14.0bn
- 時価総額
- $26.4bn
株価 $315.53 · 100株 3万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $12.2bn | $13.0bn | $14.0bn |
| 成長率 | — | 7.0% | 7.2% |
| 総利益 | $3.4bn | $3.6bn | $4.0bn |
| 総利益率 | 27.7% | 27.9% | 28.8% |
| 販管費 | $2.0bn | $2.2bn | $2.2bn |
| 販管費率 | 16.6% | 17.1% | 15.9% |
| 営利 | $726m | $1.1bn | $1.4bn |
| 営利率 | 6.0% | 8.4% | 9.9% |
| 純利益 | $418m | $746m | $877m |
| PBR | 3.4 | 3.3 | 3.1 |
| PSR | 2.2 | 2.0 | 1.9 |
| PGPR | 7.8 | 7.3 | 6.6 |
| PER | 63 | 35 | 30 |
| ﾈｯﾄｷｬｯｼｭ | ▲$5.6bn | ▲$4.6bn | ▲$5.6bn |
| EV/EBITDA | 24.5 | 17.9 | 15.5 |
| Rule of 40 | — | 15% | 17% |
| セールス効率 | — | 124% | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）